recall
saveBreckenridge Pharmaceutical, Inc recall (Cls II)
April 30, 2025updated 5mo ago
community read0 votes
Duloxetine Delayed-Release Capsules USP, 60 mg, 1000-count bottles, Rx Only, Manufactured by Towa Pharmaceutical Europe, S.L., Distributed by Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922, NDC# 51991-748-10 — Reason: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit. — Status: Ongoing
view source ↗Data sources
last refreshed 41m ago
Found something off?
same company · ±60 days · 5
- recallBreckenridge Pharmaceutical, Inc recall (Cls II)Apr 30, 2025
- recallBreckenridge Pharmaceutical, Inc. recall (Cls II)Apr 9, 2025
- recallBreckenridge Pharmaceutical, Inc. recall (Cls II)Mar 19, 2025
- recallBreckenridge Pharmaceutical, Inc. recall (Cls II)Mar 19, 2025
- recallBreckenridge Pharmaceutical, Inc. recall (Cls II)Mar 19, 2025
comments(0)
5-min edit window · permanent after that